Fitzsimon_menu

Eye on innovators.

We feature regular updates on innovators who are making advances in health and care through the work they do here on the Fitzsimons Innovation Community campus.

THIS MONTH’S FEATURE

CU Center for Bioengineering: Intersection of Engineering, Technology, Medicine, and Science

The University of Colorado (CU) Center for Bioengineering (the Center) is part of the CU School of Medicine. The Center innovates healthcare technology through cross-disciplinary training and collaborations between engineering and health sciences. Its mission is to improve human health through the application of engineering principles, ideas, methods, and inventions to train students to solve important clinical problems.
Read More

Previous Innovation Spotlights:

CU Center for Bioengineering: Intersection of Engineering, Technology, Medicine, and Science
December 09, 2025

CU Center for Bioengineering: Intersection of Engineering, Technology, Medicine, and Science

The University of Colorado (CU) Center for Bioengineering (the Center) is part of the CU School of Medicine. The Center innovates healthcare technology through cross-disciplinary training and collaborations between engineering and health sciences. Its mission is to improve human health through the application of engineering principles, ideas, methods, and inventions to train students to solve important clinical problems.

READ MORE

PHAXTEC: Scaling a Natural Alternative to Plastics
October 17, 2025

PHAXTEC: Scaling a Natural Alternative to Plastics

PHAXTEC is a fast-growing start-up commercializing polyhydroxyalkanoates (PHA)—a breakthrough natural biomaterial to replace fossil-based, non-biodegradable plastics. Its patent-protected process converts renewable and waste greenhouse gases into PHA, unlocking sustainable solutions for packaging, personal care, agriculture, textiles, automotive, and more. PHA can replace over 50% of the world’s fossil plastics.

READ MORE

Onconaut: Targeting Metastatic Colorectal Cancer and Other Cancers
September 22, 2025

Onconaut: Targeting Metastatic Colorectal Cancer and Other Cancers

Onconaut Therapeutics develops breakthrough cancer therapies that target CHD1L, an oncogenic driver in colorectal and other metastatic cancers. Onconaut’s CHD1L inhibitors halt tumor progression, inhibit metastatic spread, induce PARthanatos—a unique form of cell death—and synergize with existing treatments, offering transformative, life-extending options for patients facing limited and ineffective therapies.

READ MORE

Alta Biotech: Accelerating Discovery with High-Quality Plasmid DNA
August 17, 2025

Alta Biotech: Accelerating Discovery with High-Quality Plasmid DNA

Alta Biotech provides a broad range of molecular biology services with a core specialization in high-quality plasmid DNA preparation, supporting research, therapeutic development, and diagnostics across biotech and pharmaceutical industries.

READ MORE

Pathways Bioscience: Enhancing Wellness Through Science-Backed Supplements
June 23, 2025

Pathways Bioscience: Enhancing Wellness Through Science-Backed Supplements

Pathways Bioscience is a health-focused company that enhances wellness through science-backed supplements like PB125®. With Nrf2-activating ingredients, the company supports individuals in managing oxidative stress and promoting healthy aging, while advancing research in cellular health and longevity.

READ MORE

RefinedScience: Unlocking the Power of Real-World Clinical Data & Single-Cell Multi-omics to Accelerate Breakthroughs in Precision Medicine
November 22, 2024

RefinedScience: Unlocking the Power of Real-World Clinical Data & Single-Cell Multi-omics to Accelerate Breakthroughs in Precision Medicine

RefinedScience team of experts in clinical medicine, molecular and cellular biology, data science and pharma turn insights into advancements in care. Through the power of big data, single cell omics and AI RefinedScience aim to identify effective therapies, diagnostics and other key breakthroughs and deliver them to the patients who need them the most.

READ MORE